Medtronic Launches Drug-Coated Balloon for Peripheral Artery Disease in U.S.

Medtronic plc (NYSE: MDT) announced yesterday that its IN.PACT Admiral drug-coated balloon (DCB), approved last month by the FDA, is now available for use in the U.S. The first uses of this new addition to the interventional armamentarium were in New York, Michigan, Arizona, and Louisiana. The IN.PACT Admiral is the second such device approved by the FDA, the first being Bard's Lutonix back in October.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news